Cadence Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Cadence Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$360K	Sell	96,589 -323,059	-77%	-$1.37M	0.09%	208
2020 Q2	$1.83M	Buy	419,648 +101,539	+32%	+$456K	0.27%	90
2020 Q1	$1.21M	Buy	+318,109	New	+$1.56M	0.2%	157
2019 Q4	–	Sell	-175,000	Closed	-$737K	–	477
2019 Q3	$737K	Sell	175,000 -337,095	-66%	-$1.44M	0.1%	293
2019 Q2	$2.38M	Sell	512,095 -17,134	-3%	-$79.8K	0.24%	130
2019 Q1	$2.81M	Buy	529,229 +209,882	+66%	+$958K	0.25%	105
2018 Q4	$1.18M	Buy	+319,347	New	+$1.12M	0.12%	241

Other funds holding BDSI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Cadence Capital Management's BDSI Position: Q3 2020 in Review

Cadence Capital Management reduced its BioDelivery Sciences International, Inc. (BDSI) stake by 77% in Q3 2020, selling an estimated $1.37M and leaving 96,589 shares worth $360K. The position accounts for 0.09% of the portfolio, ranked #208.

Cadence Capital Management first reported a position in BDSI in Q4 2018 and has held it in 7 quarters since. The position peaked at $2.81M in Q1 2019. 147 funds tracked by Wall St. Rank hold BDSI as of Q3 2020.

Cadence Capital Management held 96,589 shares of BioDelivery Sciences International, Inc. worth $360K as of Q3 2020.
Cadence Capital Management sold 323,059 BioDelivery Sciences International, Inc. shares in Q3 2020, an estimated $1.37M.
BioDelivery Sciences International, Inc. made up 0.09% of Cadence Capital Management's portfolio in Q3 2020, its #208 holding.
Cadence Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2018 and has held it in 7 quarters since.
Cadence Capital Management's BioDelivery Sciences International, Inc. position peaked at $2.81M in Q1 2019.
147 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.